Zai Lab’s DLL3 ADC Emerges As New Force In ES-SCLC Race

 
• By Dexter Jie Yan
  
lung cancer
Zai Lab joins the race for best-in-disease treament for small cell lung cancer. • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Clinical Trials

More from Scrip